Biontech in the fight against cancer: new partnership with the USA enthusiastic!
Biontech in the fight against cancer: new partnership with the USA enthusiastic!
New York, USA - The biotechnology company Biontech recently announced a partnership with the US company Bristol Myers Squibb. This cooperation aims to develop innovative therapies to combat cancer. According to Welt This is an important step for biontech that extends its focus on new cancer treatment.
Bristol Myers Squibb, based in Princeton, New Jersey, was founded in 1887. The company has a market capitalization of $ 99.3 billion and expects adjusted profit of $ 6.843 per share for the current financial year. With a dividend of 5.1%, the company is perceived as an attractive dividend payer. In the current market performance, it can be observed that the share fell by 13.7% in 2025, but had an annual increase of 19.24%. These figures were provided by Aaii
market analysis and investment opportunities
The biotechnology market grew to around $ 497 billion in 2020 and is to expand with an annual growth rate of over 9.4% by 2027. The increasing frequency of chronic diseases promotes new medication, which offers numerous opportunities for companies such as Biontech and Bristol Myers Squibb. In the past, the industry has experienced innovation bumps through progress in molecular biology, which led to new disciplines such as genomics and proteomics, as gm insights
Pfizer, another leading company in biotechnology, has a market capitalization of $ 133.4 billion. However, the share fell by 11.6% in 2025 and has recorded an increase of 0.6% in the last five trading days. The profit per share is estimated at $ 2.998, and the dividend is 7.3%. Despite a lower value in the competition assessment, Pfizer receives a high growth assessment of 87, which lies above that of Bristol Myers Squibb that has a value of 73. These valuable insights also come from AAII.
research and development in focus
The partnership between Biontech and Bristol Myers Squibb emphasizes the need for innovative research and development approaches in biotechnology. Government initiatives to promote biotechnology in developing countries and new guidelines in the USA support this sector. Companies like Biontech are therefore at the top of an exciting phase in medication development.
In addition, it should be noted that combating cancer through new therapeutic approaches is of great importance, and the cooperation between these companies could offer potentially life -changing solutions. Developments in biotechnology are persecuted with great interest, both investors and health experts worldwide.
Subscribers to the World Podcast "Everything on Shares" can expect further insights and analyzes for the current development of the biotechnology industry, including relevant articles and newsletter for world plus subscribers.
| Details | |
|---|---|
| Ort | New York, USA |
| Quellen | |